Arthritis and Inflammation
We are trying to better understand the process of pain, inflammation and joint damage in the development of rheumatoid arthritis. Our studies have led to development of antibodies that an intervene in the inflammatory process and these are being commercialised by Garvan spin-off G2 Therapies Ltd. Other projects are based on dissecting the immune cells’ signalling pathways, again with the express purpose of finding points of intervention that may help control inflammatory conditions, such as asthma, arthritis and multiple sclerosis.
Staff
|
|
 Research Assistant Edwin Ho
|
|
|
|
|
|
Research Officer
Research Assistant
Research Assistant
News
New findings connect diet and intestinal bacteria with healthier immune systems
MEDIA RELEASE:
29 Oct 2009
Insoluble dietary fibre, or roughage, not only keeps you regular, there is evidence to suggest it also plays a vital role in keeping many diseases at bay. Published tomorrow in Nature, breakthrough research by a Garvan team describes a mechanism that links diet, gut bacteria and the immune system.
Garvan immunology students win main prizes at ASI conference
19 Dec 2008
For the second year in a row, a PhD student from Garvan has won the very prestigious New Investigator Award at the annual Australasian Society for Immunology (ASI) conference, held last week in Canberra. The 2008 winner is Alexis Vogelzang.
Garvan student receives recognition at international conference
11 Jul 2006
Bennett Shum, PhD student in Garvan's Immunology & Inflammation Research Program, has been awarded the ICF Outstanding Scholar Award. Bennett & colleagues recently found a link between Asthma and Obesity, a fatty acid binding protein called aP2.
